| Journal: | Ciencia & saude coletiva |
| Database: | PERIÓDICA |
| System number: | 000294061 |
| ISSN: | 1413-8123 |
| Authors: | Rozenfeld, Suely1 |
| Institutions: | 1Fundacao Instituto Oswaldo Cruz, Escola Nacional de Saude Publica, Rio de Janeiro. Brasil |
| Year: | 2007 |
| Season: | Mar-Abr |
| Volumen: | 12 |
| Number: | 2 |
| Pages: | 437-442 |
| Country: | Brasil |
| Language: | Portugués |
| Document type: | Artículo |
| Approach: | Analítico |
| English abstract | In 2002, the Women's Health Initiative (WHI) study was interrupted as evidence indicated that the use of hormones increased the risk of cardiovascular disease and of breast cancer. Since then scientific literature has pointed to three nuclei of interest for that issue: women, the doctor and the pharmaceutical industry. Regarding women, the following issues are emphasized: the cultural aspects of menopause, the feminist movements' struggle and the absence of enough epidemiological studies. With respect to doctors the lack of information on the safety of drugs is an important topic. Regarding the pharmaceutical industry the prevailing motivation is their economic interests |
| Portuguese abstract | Em 2002, o estudo Women's Health Iniciative (WHI) foi interrompido após as estimativas revelarem que o uso dos hormônios aumentava o risco de doenças cardiovasculares e de câncer de mama. A literatura publicada após o ocorrido aponta três núcleos de interesse: a mulher, o médico e a indústria farmacêutica. Com relação à mulher, destacam-se os aspectos culturais da menopausa, a luta dos movimentos feministas, a escassez de estudos epidemiológicos. Com relação ao médico, é assinalada a precariedade de informação sobre segurança no uso dos fármacos. Com relação à indústria farmacêutica, destaca-se a motivação econômica |
| Disciplines: | Medicina |
| Keyword: | Farmacología, Ginecología y obstetricia, Salud pública, Terapia hormonal, Riesgos, Estrógenos, Menopausia, Industria farmacéutica, Etica |
| Keyword: | Medicine, Gynecology and obstetrics, Pharmacology, Public health, Hormonal therapy, Risks, Estrogens, Menopause, Pharmaceutical industry, Ethics |
| Full text: | Texto completo (Ver HTML) |
